11 Best Growth Company Stocks To Buy Now

Page 3 of 12

10. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

– Number of Hedge Funds With Long Positions (as of March 31): 52

– Aggregate Value of Hedge Funds’ Holdings (as of March 31): $2.5 billion

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is a biopharmaceutical company serving people suffering from very rare disorders. The company has a global presence, selling its products primarily in the U.S, as well as in Europe, Japan, and other Asia Pacific countries. The company’s major products include Soliris (Hematology/Nephrology), Strensiq, and Kanuma (Metabolic Disorders). Revenue for the 12 months ended December 2016 amounted to $3 billion, almost double the $1.55 billion reported three years earlier. A total of 52 hedge funds in our system held shares in Alexion Pharmaceuticals at the end of the first quarter, up from 50 a quarter earlier.

11 Best Growth Company Stocks To Buy Now

Looker_Studio/Shutterstock.com

Follow Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)

Page 3 of 12